June 6, 2024—Horiba has announced that its high-throughput Yumizen H2500 hematology analyzer has received FDA 510(k) clearance and is available for sale in the United States. Designed for mid- to large-volume laboratories, the analyzer processes 120 samples per hour and reports a complete blood count and white blood cell differential results, plus a total immaturity measurement for leukocyte count, in one run from a single blood sample. Other offerings include a nucleated red blood cell count, which is platelet aggregate interference-free, three new fluorescence-free large platelet parameters, and six controlled parameters for body fluid analysis.
The instrument can stand alone or be applied as part of the fully automated modular solution HELO 2.0 by combining with a tracking system. Up to six Yumizen H2500 analyzers and six slide preparation systems can be installed on one track, with more than 200 preloaded rules available in the hematology validation station.